News | January 01, 2023
Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Miravo to remain a Canadian controlled and operated company following closing of the transaction
The scheme is subject to statutory and regulatory approvals as may be necessary.
The product is backed by required scientific proof and comparative bioequivalence studies
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
Subscribe To Our Newsletter & Stay Updated
